Search results
Signs of Alzheimer’s were everywhere. Then his brain improved | CNN
CNN.com· 3 days agoSanjay Gupta is a practicing neurosurgeon and best-selling author on brain health. Preventive...
Roche ramps up obesity-drug competition with early-stage trial results
Market Watch· 5 days agoThe race to develop powerful new weight-loss drugs grew even more heated on Thursday as Roche...
The #1 Breakfast To Help You Poop First Thing in the Morning
Health.com· 8 hours agoHaving difficulty having a morning bowel movement can throw off your entire day. Regular morning...
Roche's experimental obesity drug shows promising early stage results
United Press International via Yahoo News· 5 days agoSwiss drug company Roche on Thursday said its experimental obesity treatment helped people lose a...
Roche says weight loss drug shows promising results in early trial
CNBC· 5 days agoRoche on Thursday said its experimental weight loss drug showed promising results in an early-stage...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoAll test participants achieved more than 5% weight loss at 24 weeks, with 70% having lost over 15%, and 45% over 20% weight loss, noting a normalized ...
Reality Star issues bold message to Kelly Clarkson about weight loss drugs
Newsweek· 5 days agoKelly Clarkson's recent revelation that she is taking a weight loss medication made headlines — but...
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People...
Benzinga· 5 days ago– Over 24 weeks, a once-weekly subcutaneous injection of CT-388 achieved a clinically meaningful and statistically significant mean placebo-adjusted weight loss of 18.8% (p < 0.001) – – At week 24, 100% of CT-388
